Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Nokia and Agilent rise; Alexion, Kirkland's fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:

A : 58.66 (+4.60%)
KIRK : 9.01 (-9.90%)
DSW : 16.21 (-8.16%)
NOK : 6.54 (+5.31%)
ALXN : 104.64 (-9.34%)
TTWO : 72.83 (+5.49%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ: ALXN). Such investors...

ALXN : 104.64 (-9.34%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alexion Pharmaceuticals, Inc. - ALXN

Pomerantz LLP is investigating claims on behalf of investors of Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ: ALXN). Such investors are advised to contact Robert S. Willoughby at...

ALXN : 104.64 (-9.34%)
After Yesterday's Decline of 8.33%, Alexion Pharmaceuticals Offers Investors Better Value

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $102.47 to a high of $112.65. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day...

ALXN : 104.64 (-9.34%)
Alexion Announces Executive Leadership Changes

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced the following changes to its executive leadership team:

BXLT : 46.02 (-0.39%)
ALXN : 104.64 (-9.34%)
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Alexion Pharmaceuticals, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ: ALXN) investors concerning the...

ALXN : 104.64 (-9.34%)
Alexion's (ALXN) Strensiq Results Positive in Long-Term Study

Alexion Pharmaceuticals, Inc. (ALXN) announced that researchers presented encouraging data on Strensiq at the European Calcified Tissue Society (ECTS) Congress in Austria.

AGLE : 5.57 (-10.16%)
VVUS : 1.12 (+3.70%)
MEIP : 1.65 (+0.61%)
ALXN : 104.64 (-9.34%)
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal

Quite a few deals were announced this week including by companies like Biogen (BIIB).

SGMO : 8.20 (+10.07%)
AKBA : 13.95 (+0.14%)
VRTX : 116.59 (-1.98%)
IONS : 45.14 (+0.85%)
REGN : 461.37 (+0.08%)
ALXN : 104.64 (-9.34%)
BIIB : 248.10 (-0.78%)
Rady Children's Institute for Genomic Medicine and Alexion Pharmaceuticals Partner to Speed the Diagnosis of Rare Genetic Disorders in Newborns

The Rady Children's Institute for Genomic Medicine (RCIGM) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced a strategic partnership to accelerate the diagnosis of critically-ill...

ALXN : 104.64 (-9.34%)
Long-term Data Confirm Benefits of Treatment with Strensiq(R) (asfotase alfa) in Adolescents and Adults with Hypophosphatasia (HPP) Through Five Years

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that researchers presented data showing that the rapid benefits of Strensiq(R) (asfotase alfa) achieved in adolescents and adults...

ALXN : 104.64 (-9.34%)
Alexion Global Headquarters Earns Highest LEED(R) Green Building Certification

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and The Connecticut Green Building Council (CTGBC) today announced that Alexion's global headquarters at 100 College Street in New Haven has achieved...

ALXN : 104.64 (-9.34%)
Biotech Stock Roundup: Regeneron, BioMarin Report Q1, Kite Down on Patient Death

Kite's (KITE) shares were hit by news regarding a patient death resulting from cerebral edema.

CNAT : 5.30 (unch)
ARRY : 8.39 (-0.83%)
BMRN : 88.36 (-2.35%)
ABBV : 65.84 (+0.61%)
REGN : 461.37 (+0.08%)
KITE : 70.96 (-0.85%)
ALXN : 104.64 (-9.34%)
What Are We Waiting For?

What Are We Waiting For?

MOS : 23.32 (+0.95%)
HAL : 47.60 (+1.02%)
GDDY : 40.53 (-0.47%)
AAOI : 69.15 (-2.93%)
COP : 46.76 (-0.36%)
SQNS : 4.12 (+1.23%)
BIDU : 191.80 (+0.06%)
INCY : 136.16 (+1.29%)
IPHI : 40.45 (-1.68%)
ALXN : 104.64 (-9.34%)
Alexion Pharmaceuticals Set to Possibly Rebound After Yesterday's Selloff of 4.95%

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $122.02 to a high of $129.99. Yesterday, the shares fell 5.0%, which took the trading range below the 3-day...

ALXN : 104.64 (-9.34%)
Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene

Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene

EW : 113.54 (-0.48%)
CNC : 73.99 (-0.04%)
REGN : 461.37 (+0.08%)
ALGN : 138.22 (+0.09%)
ALXN : 104.64 (-9.34%)
5 Healthcare Innovators I'm Still Buying

5 Healthcare Innovators I'm Still Buying

EW : 113.54 (-0.48%)
CNC : 73.99 (-0.04%)
REGN : 461.37 (+0.08%)
ALGN : 138.22 (+0.09%)
ALXN : 104.64 (-9.34%)
5 Healthcare Innovators I'm Still Buying

5 Healthcare Innovators I'm Still Buying

EW : 113.54 (-0.48%)
CNC : 73.99 (-0.04%)
REGN : 461.37 (+0.08%)
ALGN : 138.22 (+0.09%)
ALXN : 104.64 (-9.34%)
Watch for Alexion Pharmaceuticals to Potentially Pullback After Gaining 1.95% Yesterday

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $127.15 to a high of $130.71. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day...

ALXN : 104.64 (-9.34%)
Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View

Alexion Pharmaceuticals, Inc.'s (ALXN) first-quarter 2017 earnings (including stock-based compensation expense) of $1.20 per share compared with the year ago earnings of 76 cents. The reported figure surpassed...

HSKA : 98.06 (+1.79%)
GALE : 0.57 (+1.79%)
INFI : 1.81 (+1.12%)
ALXN : 104.64 (-9.34%)
Alexion (ALXN) Tops Q1 Earnings, Sales; Shares Up

Alexion surpassed earnings and sales expectations in the first quarter of 2017.

ALXN : 104.64 (-9.34%)

Van Meerten Stock Picks

5 All Time High Large Caps for Momentum Investors
This morning I wanted to find 5 Large Caps that hit All Time Highs that might be of interest to Momentum Investors.
AON +0.19 , BAP -0.78 , BF.B -3.54 , VEEV -1.58 , ROL +0.22
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Jun E-mini S&Ps ( ESM17 +0.18%) this morning are up +0.14% and European stocks are up +0.68% on signs of strength in the European economy. The Eurozone May Markit manufacturing PMI unexpectedly rose +0.5 to 57.0,... Read More

Chart of the Day

AxoGen (AXGN) is the Barchart Chart of the Day.  The medical company has a Trend Spotter buy signal, a Weighted Alpha of 163.94+ and gained 175.23% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed 2 1/2 to 5 ½ cents lower on Turnaround Tuesday. The dollar was stronger, and some crop condition ratings were better than expected in individual states. Dr. Michael Cordonnier increased his 2016/17 Brazil corn production to...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.